Events|

SHL Medical attends PDA Aseptic in South Korea

Shl At Pda Aseptic Korea 2024
We invite you to visit our tabletop #3 to explore Elexy up close and engage with our members

SHL Medical is excited to announce our participation in the PDA Aseptic Processing of Biopharmaceuticals Conference 2024, taking place from October 29 – 30 in Incheon, South Korea. This event brings together global leaders in biopharmaceutical processing, offering a platform for knowledge exchange, innovation, and collaboration.

SHL’s Nagisa Kobashi, MSc is set to speak in a tech talk session on October 29 at 1:00 PM KST and share more insights on Elexy™, the latest innovative solution in our device offerings. Elexy is a versatile, electromechanical autoinjector that features a reusable power unit compatible with drug cassettes containing a pre-filled syringe (PFS) or a cartridge. The presentation will explore how Elexy is setting new standards in versatility by enabling a wider choice of injection profiles.

Additionally, attendees can engage with SHL’s representatives at our tabletop #3 to get a personal demonstration of Elexy and learn more about our comprehensive portfolio of drug delivery systems, including Molly® and Maggie® autoinjectors. We welcome pharma professionals and other industry leaders to drop by and discuss how SHL Medical’s vertically integrated manufacturing capabilities and global reach can support the evolving needs of the drug delivery industry.

 

 

Meet our speaker

Topic

Speaker

Time

Elexy™: SHL Medical’s drug-agnostic electromechanical device platform designed to facilitate the flexible development of combination products

Nagisa Kobashi, MSc

Product Manager, Emerging Tech. and Digital Health at SHL Medical

October 30

12:30 PM KST 

Where  : Sheraton Grand Incheon Hotel, Incheon, South Korea 

When   : October 29 – 30 | Tabletop #3

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News